Apyx Medical APYX 深 沪
已收盘 08-21 16:00:00 美东时间
3.12
+0.090
+2.97%
华盛通- 最 高3.1704
- 今 开3.05
- 成交量 5.29万股
- 最 低 3.04
- 昨 收 3.03
- 总市值 1.31亿
- 52周最高 5.08
- 市盈率 静 --
- 换手率 0.13%
- 52周最低 1.7001
- 委 比 -98.55%
- 总股本 4212.40万
- 历史最高 17.50
- 量 比 0.44
- 振 幅 4.30%
- 历史最低 0.7554
- 每 手 1
- 风险率 0.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Apyx Medical Q2 EPS $(0.07) Beats $(0.08) Estimate, Sales $13.884M Beat $13.175M Estimate
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 22.22 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $13.884 million wh...
08-07 04:24
Apyx Medical 2026财年第二季度财报：AYON推动营收增长22%
Apyx Medical 2026财年第二季度营收1,388.4万美元，同比增长22.1%；每股亏损收窄至0.07美元，调整后EBITDA亏损降至70.5万美元，但经营现金流出扩大至350万美元。
08-06 21:02
美股大行评级 | 花旗上调苹果、西部数据、希捷科技、超微电脑等目标价；高盛上调蔚来"买入"评级，目标价7美元
今日重点评级关注：HC Wainwright & Co.：维持艾吉纳斯"买入"评级，目标价从23美元升至30美元；富国银行：上调Q32 Bio评级至"超配"，目标价66美元
07-14 11:36
HC Wainwright & Co. Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $7
HC Wainwright & Co. analyst Yi Chen initiates coverage on Apyx Medical (NASDAQ:APYX) with a Buy rating and announces Price Target of $7.
07-13 18:12
Apyx Medical Names Vizirgianakis Executive Chairman, Grants RSUs
An update from Apyx Medical ( ($APYX) ) is now available. On June 11, 2026, Apy...
06-18 05:30
Apyx Medical Publishes New Clinical Data In Aesthetic Surgery Journal Open Forum Highlighting Approach To Improving Cellulite And Skin Laxity
In this study, 22 patients received a single treatment session combining these modalities to address both the structural and surface level causes of cellulite and skin laxity. Results showed progressive improvement over
05-21 20:04
Apyx Medical Rides AYON Surge in Latest Earnings
Apyx Medical (($APYX)) has held its Q1 earnings call. Read on for the main high...
05-09 08:46
Apyx Medical shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY2026 sales guidance above estimates.
Apyx Medical shares are trading higher after the company reported better-than-e...
05-08 02:02
Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"
Renuvion continues to lead in minimally invasive body contouring as the trusted solution for loose skin. CLEARWATER, Fla., April 1, 2026 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ: APY...
04-01 21:30
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
